Explore Our Commitment to Insightful Biotech Research

Sequela Research delivers high-impact biotech analyses rooted in deep scientific expertise and scar-tissues shaped by prior success and failures in making the calls. Sometimes, we make contrarian calls: we believed TIGIT will fail before this became the reality across the entire class. We illuminate complex data with clarity, offering unique perspectives and benchmarking that inspire informed understanding about the probabilities of success (PoS) – the most critical metric in the valuation of many pharmaceutical and biotechnology companies. We are independent and are not sponsored by any pharmaceutical or biotechnology, investment banks or institutional investors. We do not offer investment advice, and limit our analyses to what is truly informative for the most important metric: PoS.